Arun A. Azad

Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study.

N. Lawrentschuk, P. Jackson, S. Sandhu, 2023, European urology.

Precision medicine for prostate cancer: An international perspective.

Arun A. Azad, Niall Corcoran, Anis A. Hamid, 2024, Urologic oncology.

Cost Effectiveness of Systemic Treatment Intensification for Metastatic Hormone-sensitive Prostate Cancer: Is Triplet Therapy Cost Effective?

N. Lawrentschuk, N. Sathianathen, Damien Bolton, 2023, European urology oncology.

Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis.

R. Szmulewitz, T. Iguchi, F. Gómez‐Veiga, 2023, European urology oncology.